111 related articles for article (PubMed ID: 18278072)
1. B-cell enrichment and infusion in CD4+/CD8+ T-cell depleted products for donor innate immune lymphocyte infusion: is risk of EBV-associated lymphocyte post transplantation lymphoproliferative disease a concern?
Lamb LS; Sande J
Bone Marrow Transplant; 2008 Jun; 41(11):995-6. PubMed ID: 18278072
[No Abstract] [Full Text] [Related]
2. Control of Epstein-Barr virus load and lymphoproliferative disease by maintenance of CD8+ T lymphocytes in the T lymphocyte-depleted graft after bone marrow transplantation.
Torre-Cisneros J; Román J; Torres A; Herrera C; Caston JJ; Rivero A; Mingot E; Rojas R; Martín C; Martínez F; Gómez P
J Infect Dis; 2004 Nov; 190(9):1596-9. PubMed ID: 15478063
[TBL] [Abstract][Full Text] [Related]
3. Clinical-scale single-step CD4(+) and CD8(+) cell depletion for donor innate lymphocyte infusion (DILI).
Smetak M; Kimmel B; Birkmann J; Schaefer-Eckart K; Einsele H; Wilhelm M; Kunzmann V
Bone Marrow Transplant; 2008 Apr; 41(7):643-50. PubMed ID: 18037935
[TBL] [Abstract][Full Text] [Related]
4. Epstein-Barr virus (EBV)-associated post-transplantation lymphoproliferative disorder simultaneously affecting both B and T cells after allogeneic bone marrow transplantation.
Chuhjo T; Yachie A; Kanegane H; Kimura H; Shiobara S; Nakao S
Am J Hematol; 2003 Apr; 72(4):255-8. PubMed ID: 12666136
[TBL] [Abstract][Full Text] [Related]
5. Phase I study of high-stringency CD8 depletion of donor leukocyte infusions after allogeneic hematopoietic stem cell transplantation.
Orti G; Lowdell M; Fielding A; Samuel E; Pang K; Kottaridis P; Morris E; Thomson K; Peggs K; Mackinnon S; Chakraverty R
Transplantation; 2009 Dec; 88(11):1312-8. PubMed ID: 19996931
[TBL] [Abstract][Full Text] [Related]
6. Epstein-Barr virus-associated lymphoproliferative disease after allogeneic haematopoietic stem cell transplantation: molecular monitoring and early treatment of high-risk patients.
Meijer E; Cornelissen JJ
Curr Opin Hematol; 2008 Nov; 15(6):576-85. PubMed ID: 18832928
[TBL] [Abstract][Full Text] [Related]
7. Depletion of alloreactive donor T lymphocytes by CD95-mediated activation-induced cell death retains antileukemic, antiviral, and immunoregulatory T cell immunity.
Hartwig UF; Nonn M; Khan S; Link I; Huber C; Herr W
Biol Blood Marrow Transplant; 2008 Jan; 14(1):99-109. PubMed ID: 18158966
[TBL] [Abstract][Full Text] [Related]
8. High doses of mother's lymphocyte infusion to treat EBV-positive T-cell lymphoproliferative disorders in childhood.
Wang Q; Liu H; Zhang X; Liu Q; Xing Y; Zhou X; Tong C; Zhu P
Blood; 2010 Dec; 116(26):5941-7. PubMed ID: 20926772
[TBL] [Abstract][Full Text] [Related]
9. Preventing Epstein-Barr virus lymphoproliferative disease after bone marrow transplantation.
Heslop HE
J Immunother; 2001; 24(4):283-4. PubMed ID: 11565828
[No Abstract] [Full Text] [Related]
10. Immune-cell treatment of Epstein--Barr-virus-associated lymphoproliferative disorders.
Swinnen LJ
Best Pract Res Clin Haematol; 2006; 19(4):839-47. PubMed ID: 16997187
[TBL] [Abstract][Full Text] [Related]
11. Photodynamic purging of alloreactive T cells for adoptive immunotherapy after haploidentical stem cell transplantation.
Perruccio K; Topini F; Tosti A; Carotti A; Aloisi T; Aversa F; Martelli MF; Velardi A
Blood Cells Mol Dis; 2008; 40(1):76-83. PubMed ID: 17977031
[TBL] [Abstract][Full Text] [Related]
12. [Behavior of antigen-specific CD8+ T cells in Epstein-Barr virus-related disease].
Kuzushima K
Uirusu; 2001 Jun; 51(1):43-9. PubMed ID: 11565264
[No Abstract] [Full Text] [Related]
13. T cell therapy of Epstein-Barr virus and adenovirus infections after hemopoietic stem cell transplant.
Comoli P; Basso S; Labirio M; Baldanti F; Maccario R; Locatelli F
Blood Cells Mol Dis; 2008; 40(1):68-70. PubMed ID: 17904879
[TBL] [Abstract][Full Text] [Related]
14. Allogeneic hematopoietic stem cell transplantation for Epstein-Barr virus-associated T/natural killer-cell lymphoproliferative disease in Japan.
Sato E; Ohga S; Kuroda H; Yoshiba F; Nishimura M; Nagasawa M; Inoue M; Kawa K
Am J Hematol; 2008 Sep; 83(9):721-7. PubMed ID: 18626884
[TBL] [Abstract][Full Text] [Related]
15. [Epstein-Barr virus-associated pneumonia in patients with post-transplant lymphoproliferative disease after hematopoietic stem cell transplantation].
Liu QF; Fan ZP; Luo XD; Zhang Y; Sun J
Zhonghua Yi Xue Za Zhi; 2008 Dec; 88(44):3123-6. PubMed ID: 19159594
[TBL] [Abstract][Full Text] [Related]
16. Primary cutaneous Epstein-Barr virus-related lymphoproliferative disorders in 4 immunosuppressed children.
Wallet-Faber N; Bodemer C; Blanche S; Delabesse E; Eschard C; Brousse N; Fraitag S
J Am Acad Dermatol; 2008 Jan; 58(1):74-80. PubMed ID: 17884243
[TBL] [Abstract][Full Text] [Related]
17. Identification of Epstein-Barr virus (EBV)-infected lymphocyte subtypes by flow cytometric in situ hybridization in EBV-associated lymphoproliferative diseases.
Kimura H; Miyake K; Yamauchi Y; Nishiyama K; Iwata S; Iwatsuki K; Gotoh K; Kojima S; Ito Y; Nishiyama Y
J Infect Dis; 2009 Oct; 200(7):1078-87. PubMed ID: 19698076
[TBL] [Abstract][Full Text] [Related]
18. [Epstein-Barr virus-associated B cell lymphoproliferative disorder complicated in adult T-cell leukemia].
Tanaka Y; Kondo T; Kishimoto W; Kanda J; Tashima M; Mizumoto C; Ichinohe T; Ishikawa T; Uchiyama T; Haga H; Manabe T
Rinsho Ketsueki; 2008 Apr; 49(4):263-9. PubMed ID: 18516870
[TBL] [Abstract][Full Text] [Related]
19. Prevention and treatment of Epstein-Barr virus-associated lymphoproliferative disorders in recipients of bone marrow and solid organ transplants.
Meijer E; Dekker AW; Weersink AJ; Rozenberg-Arska M; Verdonck LF
Br J Haematol; 2002 Dec; 119(3):596-607. PubMed ID: 12437632
[No Abstract] [Full Text] [Related]
20. T cell-mediated control of Epstein-Barr virus infection in humanized mice.
Yajima M; Imadome K; Nakagawa A; Watanabe S; Terashima K; Nakamura H; Ito M; Shimizu N; Yamamoto N; Fujiwara S
J Infect Dis; 2009 Nov; 200(10):1611-5. PubMed ID: 19832115
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
